Executive Summary
Adoodle’s NOXO division is focused on developing a variety of products, which may in the future modify behavior such as smoking, appetite and reaction to anxiety via the olfactory senses.
The company’s first product to reach market is called NOXO Odor Inhibitor and has the ability to alter the brain‘s ability to smell horrific odors. The odor is still there and it’s not masked, but the brain does not register its normal negative reaction to the malodor. The uniquely-formulated NOXO is based on advanced olfactory perception altering technology developed by Dr. V Ruth Pinney, who is a director of Adoodle and also heads up research efforts for the company.
NOXO Odor Inhibitor balm was recently featured in the U.S. Department of Homeland Security’s “R-Tech” newsletter.
The company solely owns the formulas for the NOXO Behavior Modification Product line. This technology and the new second-generation products have now found their way into the medical and dental arena, for testing and will shortly be available in consumer markets.
NOXO Odor Inhibitor solves the unmet need for a solution to coping with nauseating, offensive and unpleasant odors. There is a growing awareness among governments, corporations, small businesses and consumers throughout the world of the urgent need to protect workers and emergency personnel from the debilitating effects of offensive odors. First responders, homeland security personnel, government agencies, the military, healthcare and emergency services, as well as the private sector—including medical professionals, nursing homes and mortuary workers—are all natural constituencies for NOXO Odor Inhibitor because it’s a known fact that nauseating odors adversely and severely affect the concentration, capabilities and overall functioning of those exposed to them. This is a serious and ongoing problem for those at risk of exposure. And NOXO is the solution.
- * NOXO Odor Inhibitor
- * NOXO Smoking Control
- * NOXO Autism Aid
- * NOXO Memory Boost
- * NOXO Sweets Control
- * NOXO Anxiety Relief
- * NOXO Mood LIfter
- * NOXO Appetite Control
- * NOXO Nausea Relief
- * NOXO Stress Relief
- * NOXO Menopausal Support
- * NOXO Sleep Aid
- * NOXO Air Refreshener
NOXO balms, when applied topically under the nostrils, help deliver scent molecules into the nose to the olfactory bulb where the chemical and neurotransmitter messengers are dispensed into the limbic system of the brain. From there, they are forwarded to areas of the central nervous system that mediate emotional, hormonal, metabolic, and other physiological responses throughout the body.
Recently, the company announced the opening of its new research facility. The Behavioral Modification research efforts focus on monetizable olfactory perception altering technologies. The NOXO Olfactory Research Laboratory is developing new and advanced products for the company, which may have a material effect on human biological functions and neurological systems responses.
MANAGEMENT TEAM
President—Richard Stevenson—Marketing/
Vice President—Gregory Van Alfen—Director of Sales
Chief Financial Officer—Sidney Pine, CPA
Director of Research – V. Ruth Pinney, PhD
The company believes there is a tremendous need for its NOXO product line. Management also believes there will be a direct correlation between market awareness and increased demand for NOXO. Revenue is now being generated by direct sales to distributors and dealers as well as end-user customers.
Adoodle, Inc.
Authorized Shares ( common stock ) 50,000,000
Issued and outstanding 9,235,000
Float 484,000
Par Value $.001 per share
Delaware Corporation 1999
As of 12/31/2009
The company has assembled an Advisory Board that will aid in the company’s rapid growth and product marketing.
Dr. Warren H. Chaney is the Chief Executive Officer for Mind Technologies and the developer and creator of Mind Tech’s Mind Dynamic™ technologies. He has written fifteen books, seventy-four journal and magazine articles, and entries for Colliers Encyclopedia. He has also written twelve screenplays, fourteen theatrical dramas, many episodic television and theatrical productions and countless independent research studies. He has produced nine feature films and has directed eight in addition to producing and directing numerous television productions. His film and television work has won numerous awards including those for best writer and director. Dr. Chaney is recognized as one of the nation’s leaders in the area of ABS (Audio Brain Technology)
Myron Yanoff, M.D., currently is Professor and Chairman of the Department of Ophthalmology at Drexel University College of Medicine in Philadelphia PA, USA. Formerly, he was Chairman of the Department of Ophthalmology of the University of Pennsylvania and Director of the Scheie Eye Institute, both in Philadelphia PA, USA. He has been the recipient of one of the highest honors in American science − the Senior Distinguished U.S. Scientist Award (Humboldt-Award). In 1998, Ophthalmology Times named Dr. Yanoff one of the 100 Best Ophthalmologists in America. Dr. Yanoff is internationally known as a scholar, teacher, clinical innovator, and academic leader.
Michael J. Stern is President of Stern Consulting LLC a company dedicated to assisting emerging growth companies. He and his team help find value added partners and make connections to expedite the growth process. Stern Consulting also makes key introductions to help with marketing the product or technology to get it into the mainstream on a faster track. Mr. Stern is also one of the top authorities on early Disney and Beatles memorabilia. He has written seven books on the subjects. Mr. Stern also serves as an industry arbitrator for Finra.
Richard Ames retired as a stockbroker after 45 years in the financial industry and has experience in growing small companies being aware of what is needed to help them succeed. Rich has served on the board of small publicly traded medical companies. As an advisory board member, he will be aiding Adoodle expand its stockholder base because of the numerous relationships he has developed over 45 years in the financial industry. Rich will aid in the planned rapid corporate growth with Adoodle focusing on the new olfaction and behavioral modification industry.
Dr. V. Ruth Pinney is the Chief Scientist for Adoodle, Inc. She has over 30 years of experience in immunology, physiology, toxicology and indoor air quality research and development for Scripps Institute, University of California San Diego, Veteran’s Medical Center in San Diego, and the Office of Naval Research for the U.S. Navy. Dr. Pinney holds a Masters of Science in biology with emphasis in brain physiology and a Ph.D. in nutrition specializing in the area of chemical perception by smell and taste.
Victor Sonder brings more than 30 years of experience and widely recognized skills in marketing and strategic planning, copywriting, art direction, film and video direction/production to his role as member of the Adoodle Advisory Board, Victor began his career as a founding partner in SonderLevitt Advertising, a full-service agency at the forefront of the “creative revolution” on the East Coast. Over the years Victor has gained expertise in virtually every phase of the marketplace, from retail political, business-to-business and package goods to fast food, food service and high tech. His work in print, collateral design, radio, television and out-of-home advertising has been recognized nationally by the Clio Awards, New York Film Festival, Hollywood Radio & Television Awards, ADDY Awards and The One Club, among many others.
Roland “Rick” Perry is the Managing Director of Institutional Analyst Inc. (IA), an independent investment research and investor relations firm, as well as editor of eight industry specific investment reviews. He is the founder of the Chicago Stock, Bond & Futures Assoc., and of Blank Check Capital Corp., which recently participated in Wall Street’s first “Ultra Mini™” blank check offering, as President of Life Sciences Opportunities Inc., which successfully merged with Beverly Hills based “Dr Tattoff.”IA is a leading publisher of news, perspective and market intelligence reports on the equity markets. Working with publicly traded corporations; the firm works with small-cap companies that have products or services that can be defined as "best of breed."
William Lerner, Esq. has been engaged in the private practice of corporate and securities law in New York since 1961 and in Pennsylvania since 1990. He has served as chairman of the corporate governance and nominating committee of MTM Technologies since November 2003. Bill is also a director of Rent-way, Inc., New York Stock Exchange listed company engaged in the rental-purchase industry; and Cortland Trust, Inc., a money market mutual fund distributed primarily through securities brokerage firms and commercial banks. Along with the other members of the Advisory Board Bill will help the company in providing recommendations relating to the company’s business plans and transactions.